The Venlafaxine with the cas number 93413-69-5, is also called (1)Elafax ; (2)Venlafaxina ; (3)Venlafaxine ; (4)Venlafaxinum ; (5)Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, (+-)- . It belongs to the following Product Categories such as:(1)Pharmaceutical material and intermeidates; (2)Venlafaxine; (3)Chiral Reagents; (4)Inhibitors; (5)Intermediates & Fine Chemicals; (6)Pharmaceuticals

Properties of Venlafaxine are: (1)ACD/BCF (pH 5.5): 1 ; (2)ACD/BCF (pH 7.4): 1.84 ; (3)ACD/KOC (pH 5.5): 1 ; (4)ACD/KOC (pH 7.4): 17.49 ; (5)#H bond acceptors: 3 ; (6)#H bond donors: 1 ; (7)#Freely Rotating Bonds: 6 ; (8) Polar Surface Area: 21.7Ų ; (9)Index of Refraction: 1.544 ; (10) Molar Refractivity: 82.63 cm³ ; (11)Molar Volume: 261.6 cm3 ; (12) Polarizability: 32.75 ×10^-24cm³ ; (13)Surface Tension: 41.1 dyne/cm ; (14)Density: 1.06 g/cm³ ; (15)Flash Point: 194.2 °C ; (16)Enthalpy of Vaporization: 68.34 kJ/mol ; (17)Boiling Point: 397.6 °C at 760 mmHg ; (18)Vapour Pressure: 4.92E-07 mmHg at 25°C

The Venlafaxine is used for Various types of depression include depression with anxiety and generalized anxiety disorder. Venlafaxine has many common side effects: gastrointestinal upset (nausea, thirst, anorexia, constipation and vomiting), central nervous system abnormality (vertigo, drowsiness, monstrous dreams, insomnia and nervous), paropsia, abnormal sweating and yawning, sexual dysfunction (impotence, abnormal ejaculation, decreased libido). occasional adverse reactions are weak, flatulence, tremor and excited, diarrhea, rhinitis. Adverse reactions often occur in the initial stage treatment. As treatment continues, these side effects would gradually subsided. Venlafaxine has no obvious drug dependence.

You can still convert the following datas into molecular structure :
1. SMILES: OC2(C(c1ccc(OC)cc1)CN(C)C)CCCCC2
2. InChI: InChI=1/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3